Designing micro- and nano-particles for treating rheumatoid arthritis

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1887-1897

  Mitragotri, Samir ^a   Yoo, Jin Wook ^b  

^a University of California   (United States)

^b Chosun University   (South Korea)

Author keywords

Drug carriers; Microparticles; Nanoparticles; Rheumatoid arthritis; Shape; Size; Surface chemistry; Targeted drug delivery

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; BETAMETHASONE; CELECOXIB; CHITOSAN; DEXAMETHASONE; ETANERCEPT; FOLATE RECEPTOR 2; GOLD SALT; GOLIMUMAB; HYDROXYCHLOROQUINE; IBUPROFEN; INFLIXIMAB; LEFLUNOMIDE; LIPOSOME; METHOTREXATE; NANOPARTICLE; NAPROXEN; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACIDOSIS; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CHOLESTEROL BLOOD LEVEL; CIRCULATION TIME; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG STABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPOXEMIA; IMMUNOREGULATION; INFECTION; INSULIN RESISTANCE; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; MEMBRANE PERMEABILITY; MONOTHERAPY; NEPHRITIS; NEUTROPENIA; NONHUMAN; OSTEOPOROSIS; PARTICLE SIZE; PHAGOCYTOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PURINE SYNTHESIS; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN DISEASE; SYNOVITIS; TUBERCULOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; BIOLOGICAL TRANSPORT; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 83655211421     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1109-9     Document Type: Review

References (85)

1. Y. Avnir R. Ulmansky V. Wasserman S. Even Chen M. Broyer Y. Barenholz Y. Naparstek 2008 Amphipathic weak acid glucocorticoid prodrugs remote loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis Arthritis Rheum. 58 119 129 18163482 10.1002/art.23230 1:CAS:528:DC%2BD1cXhslOjtrs%3D
2. N. Butoescu C. A. Seemayer M. Foti O. Jordan E. Doelker 2009 Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis Biomaterials 30 1772 1780 19135244 10.1016/j.biomaterials.2008.12.017 1:CAS:528:DC%2BD1MXht1ejsLg%3D
3. J. A. Champion S. Mitragotri 2006 Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 103 4930 4934 16549762 10.1073/pnas.0600997103 1:CAS:528:DC%2BD28XjsVGls70%3D
4. J. A. Champion Y. K. Katare S. Mitragotri 2007 Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J. Control. Release 121 3 9 17544538 10.1016/j.jconrel.2007.03.022 1:CAS:528: DC%2BD2sXosFeksrw%3D (Pubitemid 47126059)
5. D. Chandrasekar R. Sistla F. J. Ahmad R. K. Khar P. V. Diwan 2007 Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery J. Biomed. Mater. Res. A 82 92 103 17269145 (Pubitemid 46906494)
6. B. D. Chithrani A. A. Ghazani W. C. W. Chan 2006 Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano lett. 6 662 668 16608261 10.1021/nl052396o 1:CAS:528:DC%2BD28XhvVCjsLk%3D
7. E. R. Council 1957 Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis Ann. Rheum. Dis. 16 277 289 10.1136/ard.16.3.277
8. P. Decuzzi R. Pasqualini W. Arap M. Ferrari 2009 Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26 235 243 18712584 10.1007/s11095-008-9697-x 1:CAS:528:DC%2BD1cXhsFSjsr7P
9. N. Doshi B. Prabhakarpandian A. Rea-Ramsey K. Pant S. Sundaram S. Mitragotri 2010 Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks J. Control. Release 146 196 200 20385181 10.1016/j.jconrel.2010.04.007 1:CAS:528: DC%2BC3cXpvVSnsbw%3D
10. P. Emery F. C. Breedveld S. Hall P. Durez D. J. Chang D. Robertson A. Singh R. D. Pedersen A. S. Koenig B. Freundlich 2008 Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial Lancet 372 375 382 18635256 10.1016/S0140-6736(08) 61000-4 1:CAS:528:DC%2BD1cXpt1GqtLY%3D
11. M. Everts G. A. Koning R. J. Kok S. A. Asgeirsdottir D. Vestweber D. K. Meijer G. Storm G. Molema 2003 In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium Pharm. Res. 20 64 72 12608538 10.1023/A:1022298725165 1:CAS:528:DC%2BD3sXoslKhtg%3D%3D (Pubitemid 36152919)
12. C. Fang B. Shi Y. Y. Pei M. H. Hong J. Wu H. Z. Chen 2006 In vivo tumor targeting of tumor necrosis factoralpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size Eur. J. Pharm. Sci. 27 27 36 16150582 10.1016/j.ejps.2005.08.002 1:CAS:528:DC%2BD2MXht1OntLfI (Pubitemid 41728252)
13. M. Feldmann S. R. N. Maini 2008 Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics Immunol. Rev. 223 7 19 18613827 10.1111/j.1600-065X.2008.00626.x 1:CAS:528:DC%2BD1cXptlGlsrY%3D (Pubitemid 351986171)
14. G. S. Firestein 2003 Evolving concepts of rheumatoid arthritis Nature 423 356 361 12748655 10.1038/nature01661 1:CAS:528:DC%2BD3sXjs1ynu7c%3D (Pubitemid 40852711)
15. D. E. Furst 2010 The risk of infections with biologic therapies for rheumatoid arthritis Semin. Arthritis Rheum. 39 327 346 19117595 10.1016/j.semarthrit.2008.10.002 1:CAS:528:DC%2BC3cXjs1alt74%3D
16. T. Garrood C. Pitzalis 2006 Targeting the inflamed synovium: the quest for specificity Arthritis Rheum. 54 1055 1060 16575837 10.1002/art.21720 1:CAS:528:DC%2BD28XksVyht7w%3D (Pubitemid 43672917)
17. D. M. Gerlag E. Borges P. P. Tak H. M. Ellerby D. E. Bredesen R. Pasqualini E. Ruoslahti G. S. Firestein 2001 Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature Arthritis Res. 3 357 361 11714389 10.1186/ar327 1:CAS:528:DC%2BD38XjsVeltw%3D%3D (Pubitemid 33077115)
18. R. Gref Y. Minamitake M. T. Peracchia V. Trubetskoy V. Torchilin R. Langer 1994 Biodegradable long-circulating polymeric nanospheres Science 263 1600 1603 8128245 10.1126/science.8128245 1:CAS:528:DyaK2cXit1KktLc%3D (Pubitemid 24128361)
19. G. Gregoriadis 1995 Engineering liposomes for drug delivery: progress and problems Trends Biotechnol. 13 527 537 8595139 10.1016/S0167-7799(00)89017-4 1:CAS:528:DyaK2MXpslansbk%3D
20. I. Hafstrom K. Albertsson A. Boonen D. Van Der Heijde R. Landewe B. Svensson 2009 Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study Ann. Rheum. Dis. 68 508 513 18420939 10.1136/ard.2008.087833 1:STN:280:DC%2BD1M3gsFygtg%3D%3D
21. Y. Hattori M. Sakaguchi Y. Maitani 2006 Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells Biol. Pharm. Bull. 29 1516 1520 16819203 10.1248/bpb.29.1516 1:CAS:528:DC%2BD28XovFKqtLk%3D
22. J. Hollander E. Brown R. Jessar C. Brown 1951 Comparative effects of use of hydrocortisone as a local antiarthritic agent JAMA 147 1629 1635 10.1001/jama.1951.03670340019005 1:STN:280:DyaG38%2FhtVGhtw%3D%3D
23. J. D. Hood M. Bednarski R. Frausto S. Guccione R. A. Reisfeld R. Xiang D. A. Cheresh 2002 Tumor regression by targeted gene delivery to the neovasculature Science 296 2404 2407 12089446 10.1126/science.1070200 1:CAS:528:DC%2BD38XltFWksrk%3D (Pubitemid 34734217)
24. E. Horisawa T. Hirota S. Kawazoe J. Yamada H. Yamamoto H. Takeuchi Y. Kawashima 2002 Prolonged antiinflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit Pharm. Res. 19 403 410 12033371 10.1023/A:1015123024113 1:CAS:528:DC%2BD38XjvFejsr0%3D (Pubitemid 34408936)
25. E. Horisawa K. Kubota I. Tuboi K. Sato H. Yamamoto H. Takeuchi Y. Kawashima 2002 Size-dependency of DLlactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium Pharm. Res. 19 132 139 11883639 10.1023/A:1014260513728 1:CAS:528:DC%2BD38XitVSmu7g%3D (Pubitemid 34165397)
26. T. Ishihara T. Kubota T. Choi M. Higaki 2009 Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate J. Pharmacol. Exp. Ther. 329 412 417 19244548 10.1124/jpet.108.150276 1:CAS:528:DC%2BD1MXlt1Omurs%3D
27. F. Jamar P. Chapman D. Manicourt D. Glass D. Haskard A. Peters 1997 A comparison between 111In-anti-Eselectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis Br. J. Radiol. 70 473 9227228 1:STN:280:DyaK2szntFSjsQ%3D%3D
28. M. Khoury P. Louis-Plence V. Escriou D. Noel C. Largeau C. Cantos D. Scherman C. Jorgensen F. Apparailly 2006 Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis Arthritis Rheum. 54 1867 1877 16729293 10.1002/art.21876 1:CAS:528:DC%2BD28Xms1Sju70%3D (Pubitemid 43877936)
29. Koch, A., Angiogenesis as a target in rheumatoid arthritis. Ann. Rheum. Dis., 62, ii60-ii67 (2003).
30. G. A. Koning R. M. Schiffelers M. H. Wauben R. J. Kok E. Mastrobattista G. Molema T. L. Ten Hagen G. Storm 2006 Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis Arthritis Rheum. 54 1198 1208 16575845 10.1002/art.21719 1:CAS:528:DC%2BD28XksVyhtLg%3D (Pubitemid 43672932)
31. R. C. Lawrence C. G. Helmick F. C. Arnett R. A. Deyo D. T. Felson E. H. Giannini S. P. Heyse R. Hirsch M. C. Hochberg G. G. Hunder M. H. Liang S. R. Pillemer V. D. Steen F. Wolfe 1998 Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum. 41 778 799 9588729 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V 1:STN:280:DyaK1c3kvVWnsQ%3D%3D (Pubitemid 28225778)
32. J. R. Levick 1990 Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure J. Rheumatol. 17 579 582 2359066 1:STN:280:DyaK3c3psVaisA%3D%3D (Pubitemid 20201730)
33. L. S. Liang J. Jackson W. Min V. Risovic K. M. Wasan H. M. Burt 2004 Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint J. Pharm. Sci. 93 943 956 14999731 10.1002/jps.20031 1:CAS:528:DC%2BD2cXivF2ltr4%3D (Pubitemid 38420405)
34. L. S. Liang W. Wong H. M. Burt 2005 Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits J. Pharm. Sci. 94 1204 1215 15858840 10.1002/jps.20341 1:CAS:528:DC%2BD2MXkvF2qtL4%3D (Pubitemid 40904185)
35. R. T. Liggins T. Cruz W. Min L. Liang W. L. Hunter H. M. Burt 2004 Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits Inflamm. Res. 53 363 372 15316667 10.1007/s00011-004-1273-1 1:CAS:528: DC%2BD2cXns1ejs7c%3D (Pubitemid 39141750)
36. J. Listing A. Strangfeld S. Kary R. Rau U. Von Hinueber M. Stoyanova-Scholz E. Gromnica-Ihle C. Antoni P. Herzer J. Kekow M. Schneider A. Zink 2005 Infections in patients with rheumatoid arthritis treated with biologic agents Arthritis Rheum. 52 3403 3412 16255017 10.1002/art.21386 1:CAS:528:DC%2BD2MXht1KrtbfF (Pubitemid 41612206)
37. S. Mansouri Y. Cuie F. Winnik Q. Shi P. Lavigne M. Benderdour E. Beaumont J. C. Fernandes 2006 Characterization of folate-chitosan-DNA nanoparticles for gene therapy Biomaterials 27 2060 2065 16202449 10.1016/j.biomaterials.2005.09. 020 1:CAS:528:DC%2BD2MXht12isb7J (Pubitemid 41759500)
38. J. Mcneil J. Binette 2001 Prevalence of disabilities and associated health conditions among adults-United States, 1999 MMWR Morb. Mortal. Wkly. Rep. 50 120 125
39. J. M. Metselaar M. H. Wauben J. P. Wagenaar-Hilbers O. C. Boerman G. Storm 2003 Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes Arthritis Rheum. 48 2059 2066 12847701 10.1002/art.11140 1:CAS:528:DC%2BD3sXmtFarur4%3D (Pubitemid 36828702)
40. J. M. Metselaar W. B. Van Den Berg A. E. Holthuysen M. H. Wauben G. Storm P. L. Van Lent 2004 Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis Ann. Rheum. Dis. 63 348 353 15020326 10.1136/ard.2003.009944 1:CAS:528: DC%2BD2cXjs1ahsrk%3D (Pubitemid 38453298)
41. M. C. Montesinos M. Takedachi L. F. Thompson T. F. Wilder P. Fernandez B. N. Cronstein 2007 The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice Arthritis Rheum. 56 1440 1445 17469101 10.1002/art.22643 1:CAS:528:DC%2BD2sXmsFart7s%3D (Pubitemid 46764071)
42. R. H. Muller K. Mader S. Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 161 177 10840199 10.1016/S0939-6411(00)00087-4 1:CAS:528: DC%2BD3cXjslyisrg%3D (Pubitemid 30326695)
43. D. Naor S. Nedvetzki 2003 CD44 in rheumatoid arthritis Arthritis Res. Ther. 5 105 115 12723975 10.1186/ar746 1:CAS:528:DC%2BD3sXjtlens7Y%3D
44. V. Natarajan N. Krithica B. Madhan P. K. Sehgal 2011 Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis J. Pharm. Sci. 100 195 205 20607810 10.1002/jps.22266 1:CAS:528:DC%2BC3cXhsFegtr7I
45. J. R. O'dell C. E. Haire N. Erikson W. Drymalski W. Palmer P. J. Eckhoff V. Garwood P. Maloley L. W. Klassen S. Wees H. Klein G. F. Moore 1996 Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications N. Engl. J. Med. 334 1287 1291 8609945 10.1056/NEJM199605163342002 (Pubitemid 26138009)
46. D. E. 3. Owens N. A. Peppas 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 93 102 16303268 10.1016/j.ijpharm.2005.10.010 1:CAS:528:DC%2BD2MXht12isrvM (Pubitemid 41773257)
47. C. M. Paulos M. J. Turk G. J. Breur P. S. Low 2004 Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis Adv. Drug Deliv. Rev. 56 1205 1217 15094216 10.1016/j.addr.2004.01.012 1:CAS:528:DC%2BD2cXjtF2rtLk%3D (Pubitemid 38496516)
48. C. M. Paulos B. Varghese W. R. Widmer G. J. Breur E. Vlashi P. S. Low 2006 Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis Arthritis Res. Ther. 8 R77 16646988 10.1186/ar1944
49. T. Pincus S. B. Marcum L. F. Callahan 1992 Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone J. Rheumatol. 19 1885 1894 1294735 1:STN:280: DyaK3s7psFyktg%3D%3D (Pubitemid 23018519)
50. T. M. Piscaer C. Müller T. L. Mindt E. Lubberts J. A. Verhaar E. P. Krenning R. Schibli M. De Jong H. Weinans 2011 Imaging of activated macrophages in experimental osteoarthritis using folate targeted animal singlephoton- emission computed tomography/computed tomography Arthritis Rheum. 63 1898 1907 21437875 10.1002/art.30363
51. J. H. Ratcliffe I. M. Hunneyball C. G. Wilson A. Smith S. S. Davis 1987 Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits J. Pharm. Pharmacol. 39 290 295 2884293 10.1111/j.2042-7158.1987.tb06268.x 1:CAS:528:DyaL2sXhvVamtbo%3D (Pubitemid 17046856)
52. K. H. Roh D. C. Martin J. Lahann 2005 Biphasic Janus particles with nanoscale anisotropy Nat. Mater. 4 759 763 16184172 10.1038/nmat1486 1:CAS:528:DC%2BD2MXhtVGgu77F (Pubitemid 41397023)
53. B. Romberg W. E. Hennink G. Storm 2008 Sheddable coatings for long-circulating nanoparticles Pharm. Res. 25 55 71 17551809 10.1007/s11095-007-9348-7 1:CAS:528:DC%2BD1cXkslSnsg%3D%3D
54. K. G. Saag 2002 Glucocorticoid use in rheumatoid arthritis Curr. Rheumatol. Rep. 4 218 225 12010606 10.1007/s11926-002-0068-z
55. R. M. Schiffelers G. A. Koning T. L. Ten Hagen M. H. Fens A. J. Schraa A. P. Janssen R. J. Kok G. Molema G. Storm 2003 Anti-tumor efficacy of tumor vasculaturetargeted liposomal doxorubicin J. Control. Release 91 115 122 12932643 10.1016/S0168-3659(03)00240-2 1:CAS:528:DC%2BD3sXmsVSkurw%3D (Pubitemid 37288882)
56. F. Schmitt L. Lagopoulos P. Kauper N. Rossi N. Busso J. Barge G. Wagnieres C. Laue C. Wandrey L. Juillerat-Jeanneret 2010 Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints J. Control. Release 144 242 250 20152870 10.1016/j.jconrel.2010.02.008 1:CAS:528:DC%2BC3cXlslCrur4%3D
57. L. Senolt J. Vencovsky K. Pavelka C. Ospelt S. Gay 2009 Prospective new biological therapies for rheumatoid arthritis Autoimmun. Rev. 9 102 107 19328245 10.1016/j.autrev.2009.03.010 1:CAS:528:DC%2BD1MXhs1SjtL7M
58. G. Sharma D. T. Valenta Y. Altman S. Harvey H. Xie S. Mitragotri J. W. Smith 2010 Polymer particle shape independently influences binding and internalization by macrophages J. Control. Release 147 408 412 20691741 10.1016/j.jconrel.2010.07.116 1:CAS:528:DC%2BC3cXhtlygt7nO
59. T. Shehata K. Ogawara K. Higaki T. Kimura 2008 Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers Int. J. Pharm. 359 272 279 18486370 10.1016/j.ijpharm.2008.04.004 1:CAS:528:DC%2BD1cXmvVems7w%3D
60. Q. Shi H. Wang C. Tran X. Qiu F. M. Winnik X. Zhang K. Dai M. Benderdour J. C. Fernandes 2011 Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis J. Biomed. Biotechnol. 2011 148763 21274258 10.1155/2011/148763
61. M. S. Shive J. M. Anderson 1997 Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 28 5 24 10837562 10.1016/S0169-409X(97)00048-3 (Pubitemid 27497671)
62. L. S. Simon 2000 DMARDs in the treatment of rheumatoid arthritis: current agents and future developments Int. J. Clin. Pract. 54 243 249 10912314 1:CAS:528:DC%2BD3cXktFGis7g%3D (Pubitemid 30319211)
63. J. S. Smolen G. Steiner 2003 Therapeutic strategies for rheumatoid arthritis Nat. Rev. Drug Discov. 2 473 488 12776222 10.1038/nrd1109 1:CAS:528:DC%2BD3sXktFOhu7o%3D (Pubitemid 37361728)
64. D. H. Solomon J. N. Katz J. P. Jacobs A. M. La Tourette J. Coblyn 2002 Management of glucocorticoid induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice Arthritis Rheum. 46 3136 3142 12483716 10.1002/art.10613 (Pubitemid 35453521)
65. V. Strand R. Kimberly J. D. Isaacs 2007 Biologic therapies in rheumatology: lessons learned, future directions Nat. Rev. Drug Discov. 6 75 92 17195034 10.1038/nrd2196 1:CAS:528:DC%2BD28XhtlGktbbE (Pubitemid 46020288)
66. B. Svensson A. Boonen K. Albertsson D. Van Der Heijde C. Keller I. Hafstrom 2005 Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a twoyear randomized trial Arthritis Rheum. 52 3360 3370 16255010 10.1002/art.21298 1:CAS:528: DC%2BD2MXht1KrtbfJ (Pubitemid 41612202)
67. I. H. Tarner P. Harle U. Muller-Ladner R. E. Gay S. Gay 2005 The different stages of synovitis: acute vs chronic, early vs late and non-erosive vs erosive Best Pract. Res. Clin. Rheumatol. 19 19 35 15588969 10.1016/j.berh.2004.08.002 (Pubitemid 40003939)
68. I. H. Tarner U. Muller-Ladner 2008 Drug delivery systems for the treatment of rheumatoid arthritis Expert Opin. Drug Deliv. 5 1027 1037 18754751 10.1517/17425247.5.9.1027 1:CAS:528:DC%2BD1cXhtVGktrnN
69. T. Tomita E. Takeuchi N. Tomita R. Morishita M. Kaneko K. Yamamoto T. Nakase H. Seki K. Kato Y. Kaneda T. Ochi 1999 Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy Arthritis Rheum. 42 2532 2542 10615998 10.1002/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2 1:CAS:528:DC%2BD3cXjslagtA%3D%3D (Pubitemid 30327169)
70. V. Torchilin 2011 Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Deliv. Rev. 63 131 135 20304019 10.1016/j.addr.2010.03.011 1:CAS:528:DC%2BC3MXktF2jur4%3D
71. M. J. Turk G. J. Breur W. R. Widmer C. M. Paulos L. C. Xu L. A. Grote P. S. Low 2002 Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis Arthritis Rheum. 46 1947 1955 12124880 10.1002/art.10405 (Pubitemid 34774528)
72. A. S. Utada E. Lorenceau D. R. Link P. D. Kaplan H. A. Stone D. A. Weitz 2005 Monodisperse double emulsions generated from a microcapillary device Science 308 537 541 15845850 10.1126/science.1109164 1:CAS:528: DC%2BD2MXjtlOjtrk%3D (Pubitemid 40570581)
73. J. W. Van Der Heijden R. Oerlemans B. A. Dijkmans H. Qi C. J. Van Der Laken W. F. Lems A. L. Jackman M. C. Kraan P. P. Tak M. Ratnam G. Jansen 2009 Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients Arthritis Rheum. 60 12 21 19116913 10.1002/art.24219
74. R. F. Van Vollenhoven 2009 Treatment of rheumatoid arthritis: state of the art 2009 Nat. Rev. Rheumatol. 5 531 541 19798027 10.1038/nrrheum.2009.182
75. A. S. Vanniasinghe V. Bender N. Manolios 2009 The potential of liposomal drug delivery for the treatment of inflammatory arthritis Semin. Arthritis Rheum. 39 182 196 18926560 10.1016/j.semarthrit.2008.08.004 1:CAS:528: DC%2BD1MXhsVGmtrnM
76. W. J. Wallis P. A. Simkin W. B. Nelp 1987 Protein traffic in human synovial effusions Arthritis Rheum. 30 57 63 3814198 10.1002/art.1780300108 1:STN:280:DyaL2s7ivVaksA%3D%3D (Pubitemid 17007261)
77. Wang, D., Miller, S. C., Liu, X. M., Anderson, B., Wang, X. S., and Goldring, S. R., Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res. Ther., 9, R2 (2007).
78. F. Wolfe D. M. Mitchell J. T. Sibley J. F. Fries D. A. Bloch C. A. Williams P. W. Spitz M. Haga S. M. Kleinheksel M. A. Cathey 1994 The mortality of rheumatoid arthritis Arthritis Rheum. 37 481 494 8147925 10.1002/art. 1780370408 1:STN:280:DyaK2c7pslOrsw%3D%3D (Pubitemid 24115934)
79. J. Ye Q. Wang X. Zhou N. Zhang 2008 Injectable actaritloaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis Int. J. Pharm. 352 273 279 18054182 10.1016/j.ijpharm.2007.10.014 1:CAS:528:DC%2BD1cXitlWhtrc%3D (Pubitemid 351273921)
80. J. W. Yoo E. Chambers S. Mitragotri 2010 Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects Curr. Pharm. Des. 16 2298 2307 20618151 10.2174/138161210791920496 1:CAS:528:DC%2BC3cXhtFertrfI
81. J. W. Yoo N. Doshi S. Mitragotri 2010 Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry Macromol. Rapid Commun. 31 142 148 21590886 10.1002/marc.200900790 1:CAS:528:DC%2BC3cXos1Gjsw%3D%3D
82. J. W. Yoo S. Mitragotri 2010 Polymer particles that switch shape in response to a stimulus Proc. Natl. Acad. Sci. U. S. A. 107 11205 11210 20547873 10.1073/pnas.1000346107 1:CAS:528:DC%2BC3cXot1eksrg%3D
83. J. W. Yoo N. Doshi S. Mitragotri 2011 Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery Adv. Drug Deliv. Rev. 63 1247 1256 21605607 10.1016/j.addr.2011.05.004 1:CAS:528:DC%2BC3MXhsV2lsrzF
84. J. W. Yoo D. J. Irvine D. E. Discher S. Mitragotri 2011 Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat. Rev. Drug Discov. 10 521 535 21720407 10.1038/nrd3499 1:CAS:528:DC%2BC3MXotlClurs%3D
85. I. V. Zhigaltsev N. Maurer K. Edwards G. Karlsson P. R. Cullis 2006 Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention J. Control. Release 110 378 386 16318894 10.1016/j.jconrel.2005.10.011 1:CAS:528:DC%2BD2MXhtlert7nK (Pubitemid 41829566)